[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Rulemaking History for OTC Benign Prostatic Hypertrophy Drug Products
View by Date

Final Monographs (21 CFR 310.532):
Drug products containing active ingredients offered over-the-counter (OTC) to relieve the symptoms of benign prostatic hypertrophy

Note: This page links to PDF files which require the free Adobe Acrobat Reader.


Benign Prostatic Hypertrophy Drug Products
Advance Notice Of Proposed Rulemaking Date FR Citation
Advance Notice of Proposed Rulemaking 10/1/1982 47FR43566
Proposed Rule Date FR Citation
Tentative Final Monograph 2/20/1987 52FR5406
    Correction 4/14/1987 52FR12114
    Correction 4/30/1987 52FR15732
Final Rule Date FR Citation
Final Monograph: No GRASE active ingredients 2/27/1990 55FR6926

top arrow Back to Top     back arrow Back to Rulemaking Index

Date created: December 28, 2006; Last updated: May 4, 2007
horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research